Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Strategies in Biomarker Research
-
1. The proteomic revolution
- Dr. Larry Gold
-
2. Lipid biomarkers: lipidomics of the macrophage and plasma lipidomes
- Prof. Edward A. Dennis
- New Tools for Biomarker Research
-
5. Development of glyco-biomarkers using glycoproteomics technologies
- Dr. Hisashi Narimatsu
-
6. Circulating nucleic acids as biomarkers in cancer patients
- Prof. Klaus Pantel
- Specific Disease Applications
-
7. Biomarkers in breast cancer
- Prof. Joe Duffy
-
8. Bacterial biomarkers
- Dr. Christiane Honisch
-
9. Diabetes biomarkers
- Prof. Naveed Sattar
-
10. Gene networks, brain networks: understanding schizophrenia
- Dr. Daniel Weinberger
-
11. Biomarkers for Huntington's disease - promises and challenges
- Prof. Sarah Tabrizi
-
12. Update on fluid biomarkers for neurodegenerative diseases
- Prof. Henrik Zetterberg
-
13. Biomarkers in osteoarthritis
- Dr. Ali Mobasheri
- Biomarkers in Drug Discovery and Delivery
-
14. Pharmacogenomics: emphasis on clinical drug development
- Dr. Amelia Warner
-
15. Biomarkers in drug development: potential use and challenges
- Dr. Abdel-Bassett Halim
- Biomarkers in development, nutrition, and health
-
18. Ethnic differences in nutrition
- Prof. Jose Ordovas
-
19. Non-invasive prenatal diagnostics
- Prof. Y. M. Dennis Lo
-
20. Epigenetic biomarkers in cancer
- Prof. Bob Brown
- Archived Lectures *These may not cover the latest advances in the field
-
21. Biomarkers for Alzheimer's disease
- Prof. Henrik Zetterberg
Printable Handouts
Navigable Slide Index
- Introduction
- Human genetic variation
- “Normal” structural variation
- Objectives
- Copy number polymorphism and disease
- Copy number polymorphisms and disease (2002)
- Copy number polymorphisms and disease (2008)
- Duplicated sequences: CNV hotspots
- Structural variation and enriched gene functions
- Array comparative genomic hybridization
- Copy-number variation detection is not sufficient
- CNV characterization
- Caveats / problems with current SV detection
- A human genome structural variation project
- Sequence-based resolution of structural variation
- Genome-wide detection of structural variation
- Fine-scale structural variation map
- Summary of validated sites of structural variation
- Structural variation of the GSTM1 locus
- Structural variation map from 9 human genomes
- Frequency distribution
- Length distribution
- Sequence the structural variation
- Sequenced structural variation of APOBEC3B
- World-wide distribution of APOBEC3B deletion
- Examples of sequenced structural variation
- Clone sequencing summary
- Inferred mechanism of origin
- Sequencing reveals breakpoint heterogeneity
- Oligonucleotide array CGH of SIRPB1 region
- Method: detection of novel insertion sequences
- Distribution of 525 “novel” sequence loci
- Novel euchromatic sequences up to 130 kbp
- Array CGH of 525 “novel” sequence loci
- A structural variation map of the human genome
- Properties of “normal” structural variation
Topics Covered
- Human genetic variation
- "Normal" structural variation
- Copy number polymorphism and disease
- Duplicated sequences: copy number variant (CNV) hotspots
- Structural variation and enriched gene functions
- Array comparative genomic hybridization
- Insufficiency of CNV detection
- Sequence-based resolution of structural variation
- Genome-wide detection of structural variation
- Validated sites of structural variation
- Frequency and length distribution
- APOBEC3B
- Breakpoint heterogeneity
- Detection of novel insertion sequences
Talk Citation
Eichler, E. (2017, March 29). The future of CNVs: sequence based resolution and links to human disease 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 10, 2024, from https://doi.org/10.69645/PUNC3135.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Evan Eichler, Other: Scientific advisory board of DNAnexus, Inc. with stock options.
The future of CNVs: sequence based resolution and links to human disease 1
A selection of talks on Genetics & Epigenetics
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Evan Eichler.
I'm a Professor in the
Department of Genome Sciences
at the University of Washington.
Title of my lecture today
is The Future
of Copy Number Variation:
Sequence Based Resolution
and Links to Human Disease.
0:15
For many years,
it's been appreciated
that there's a wide spectrum
of human genetic variation,
ranging on one hand
from single base-pair changes
such as point mutations,
which can be detected
at the level of sequence,
the very large
chromosomal variations
that can be detected
through a light microscope
such as translocations,
inversions, and fusions.
What I want to focus on today
is really an intermediate
form of variation,
large scale genomic variation
typically defined
as greater
than 1 kilobase in length,
which includes
large-scale deletions, inversions,
as well as segmental duplications.
0:50
Collectively,
this type of variation
is known as
genome structural variation
and it can be thought of as really
being of two different flavors
that which varies
in terms of copy number
within a genome,
such as insertions and deletions
where an individual
may have one copy
more or less of a given sequence
with respect to another
or balanced structural
variation events,
such as translocations
and inversions
in which there is no difference
in copy number
but there's a difference
in the structure
and organization of the sequence.
Over the last few years,
there's been a number
of different approaches
that have been used
to actually characterize
the pattern
of normal structural variation.
A normal structural variation
refers to variation
that's found in individuals
who are not thought to suffer
from obvious frank disease
but in fact maybe risk factors
for that disease.
The various approaches
can be divided
into three different groups,
those dependent upon microarrays,
so these are DNA molecules
that have been affixed to slides
and measuring the relative
hybridization intensity of a test
and reference DNA sample
to assess copy number.
There are genomics-based approaches
which often compare
the sequence of one genome
against the human
reference sequence.
And population
genetic-based approaches
which look for failures
in genotyping
or evidence
of "Non-Mendelian transmission
to detect potential sites
of copy number variation."
So I'll be focusing mainly
in this talk
on genomic-based approaches
to detect copy number variation
with exquisite sequence resolution.
Hide